tiprankstipranks
Sonnet Biotherapeutics Holdings, Inc. (SONN)
:SONN
US Market
Holding SONN?
Track your performance easily

Sonnet BioTherapeutics Holdings (SONN) Financial Statements

504 Followers

Sonnet BioTherapeutics Holdings Financial Overview

Sonnet BioTherapeutics Holdings's market cap is currently ―. The company's EPS TTM is $-12.206; its P/E ratio is ―; Sonnet BioTherapeutics Holdings is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $-1.39. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 18.63K$ -10.55K
Gross Profit---$ 18.63K$ -10.55K
EBIT$ -10.87M$ -3.51M$ 8.10M$ -1.28M$ -3.72M
EBITDA$ -10.84M$ -3.48M$ 8.12M$ -1.26M$ -3.71M
Net Income Common Stockholders$ -3.13M$ -3.51M$ 365.43K$ -1.17M$ -3.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 100.00K$ 3.60M$ 3.80M$ 3.00M$ 2.27M
Total Assets$ 2.77M$ 5.80M$ 5.91M$ 5.34M$ 5.43M
Total Debt$ 130.86K$ 150.19K$ 168.94K$ 186.69K$ 203.91K
Net Debt$ 30.86K$ -3.45M$ -3.63M$ -2.81M$ -2.07M
Total Liabilities$ 3.26M$ 3.18M$ 2.86M$ 2.77M$ 5.66M
Stockholders Equity$ -485.74K$ 2.62M$ 3.05M$ 2.57M$ -225.98K
Cash Flow-
Free Cash Flow$ -3.17M$ -3.07M$ 723.79K$ -3.09M$ -4.56M
Operating Cash Flow$ -3.17M$ -3.07M$ 723.79K$ -3.09M$ -4.56M
Investing Cash Flow-$ -12.00K--$ -170.00K
Financing Cash Flow$ -234.71K$ 2.85M$ 41.00K$ 3.84M$ -17.70K
Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

Sonnet BioTherapeutics Holdings Debt to Assets

Sonnet BioTherapeutics Holdings Cash Flow

Sonnet BioTherapeutics Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis